Silverarc Capital Management »

Alx Oncology Hldgs shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Alx Oncology Hldgs shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Alx Oncology Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Alx Oncology Hldgs held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alx Oncology Hldgs by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.0M 168k 6.03

More positions owned by Silverarc Capital Management

Merus N V (MRUS)
Nuvalent Inc-a (NUVL)
Avidity Biosciences Ord (RNA)
Urogen Pharma (URGN)
Erasca (ERAS)
Insmed Call Call Option
Morphic Hldg (MORF)
Akero Therapeutics (AKRO)
Celldex Therapeutics Com New (CLDX)
Intra Cellular Therapies (ITCI)
Poseida Therapeutics I (PSTX)
Cogent Biosciences (COGT)
Insmed Com Par $.01 (INSM)
Alnylam Pharmaceuticals (ALNY)
Elutia Cl A Com (ELUT)

View all positions for Silverarc Capital Management

Top funds holding Alx Oncology Hldgs

Silverarc Capital Management
Simplex Trading

View all funds holding Alx Oncology Hldgs